Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study.

Brenda W C BongaertsSuzanne V ArnoldBernard H CharbonnelHungta ChenAndrew CooperPeter FeniciMarilia GomesLinong JiKamlesh KhuntiMikhail KosiborodJesús MedinaAntonio NicolucciMarina ShestakovaIichiro ShimomuraFengming TangHirotaka WatadaWolfgang Rathmann

Published in: BMJ open diabetes research & care (2021)

A large proportion of older DISCOVER patients received an inappropriately intensive glucose-lowering treatment across the 2 years of follow-up, with substantial regional variation. The use of high-risk medications in these patients is particularly concerning.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
physical activity
type diabetes
middle aged
patient reported outcomes
patient reported
combination therapy
community dwelling